Digitek®, also known as “digoxin”, is used by very ill patients with congestive heart failure or abnormal heart rhythms. A nationwide recall of pills was issued April 25, 2008, after it was discovered that some tablets may have been twice as thick as they were supposed to be, posing risk of over-dosage. The primary active ingredient in Digitek® is digitalis. The pills were distributed by Mylan Pharmaceuticals, Inc. under the label “Bertek,” and by UDL Laboratories, Inc. under the “UDL” label. They are manufactured by Actavis Totowa.
Symptoms of digitalis poisoning include: